Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07566039 · ClinicalTrials.gov registry record · NA
Cohort Study of PPP Injections for Athletes With Muscle Injury
A NA study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07566039 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 90 participants.
The verdict
NCT07566039, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The investigators hypothesize that a single injection of platelet-poor plasma (PPP) into an acute muscle injury will significantly improve local muscle regeneration and patient outcomes compared to the standard of care using only ultrasound-guided hematoma aspiration. Muscle regeneration will be assessed through quantitative MRI analysis. The investigators anticipate that PPP injections will lead to a measurable reduction in scar tissue and an increase in regenerated muscle tissue at the injury site over a six-month period.
Interventions
- DEVICE Platelet Poor Plasma (PPP) Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07566039
The ClinicalTrials.gov registry entry for NCT07566039 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Poor Plasma (PPP) Injection is the first listed.
NCT07566039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07566039 about?
NCT07566039 is a clinical study titled "Cohort Study of PPP Injections for Athletes With Muscle Injury". The investigators hypothesize that a single injection of platelet-poor plasma (PPP) into an acute muscle injury will significantly improve local muscle regeneration and patient outcomes compared to the standard of care using only ultrasound-guided hematoma aspiration. Muscle regeneration will be ass...
What is the current status of trial NCT07566039?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-05-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07566039?
The interventions under investigation include: Platelet Poor Plasma (PPP) Injection (DEVICE).
Who is sponsoring clinical trial NCT07566039?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.